1 |
Wang M, Mi H, Li N, Shi Q, Sun W, He T, Lin J, Jin W, Gao X, Hu B, Su C, Pan J. Association between the overall burden of comorbidity and Ct values among the older patients with Omicron infection: Mediated by inflammation. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1145044] [Reference Citation Analysis]
|
2 |
Misra AK, Rangari G, C M, Sharma S. Current management of diabetes patients with COVID-19. Expert Rev Endocrinol Metab 2023;:1-9. [PMID: 36890686 DOI: 10.1080/17446651.2023.2187375] [Reference Citation Analysis]
|
3 |
Misra AK, Rangari G, C M, Sharma S. Current management of diabetes patients with COVID-19. Expert Rev Endocrinol Metab 2023;:1-9. [PMID: 36882971 DOI: 10.1080/17446651.2023.2187215] [Reference Citation Analysis]
|
4 |
Wrona M, Skrypnik D. New-Onset Diabetes Mellitus, Hypertension, Dyslipidaemia as Sequelae of COVID-19 Infection-Systematic Review. Int J Environ Res Public Health 2022;19. [PMID: 36293857 DOI: 10.3390/ijerph192013280] [Reference Citation Analysis]
|
5 |
Ishay Y, Kenig A, Rubin L, Shamriz O, Kharouf F, Mageed R. Autoimmune Diseases Induced or Exacerbated by COVID-19: A Single Center Experience. Autoimmune Diseases 2022;2022:1-7. [DOI: 10.1155/2022/9171284] [Reference Citation Analysis]
|
6 |
Chandrashekhar Joshi S, Pozzilli P. COVID-19 Induced Diabetes: A Novel Presentation. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.110034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|